CENTOGENE NVCENTOGENE NVCENTOGENE NV

CENTOGENE NV

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪10.97 M‬EUR
‪−31.27 M‬EUR
‪46.62 M‬EUR
‪11.98 M‬
Beta (1Y)
2.51

About Centogene N.V.

CEO
Kim Stratton
Headquarters
Rostock
Employees (FY)
517
Founded
2018
ISIN
NL0014040206
FIGI
BBG00QTPGZB8
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange CENTOGENE NV stocks are traded under the ticker 39K.
CENTOGENE NV is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
39K earnings for the last quarter are −0.26 EUR per share, whereas the estimation was −0.43 EUR resulting in a 41.09% surprise. The estimated earnings for the next quarter are −0.42 EUR per share. See more details about CENTOGENE NV earnings.
CENTOGENE NV revenue for the last quarter amounts to ‪9.41 M‬ EUR despite the estimated figure of ‪29.26 M‬ EUR. In the next quarter revenue is expected to reach ‪11.29 M‬ EUR.
Yes, you can track CENTOGENE NV financials in yearly and quarterly reports right on TradingView.
No, 39K doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 39K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CENTOGENE NV stock right from TradingView charts — choose your broker and connect to your account.
39K reached its all-time high on Mar 19, 2020 with the price of 31.000 EUR, and its all-time low was 0.390 EUR and was reached on Apr 19, 2024. View more price dynamics on 39K chart.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 517.00 employees. See our rating of the largest employees — is CENTOGENE NV on this list?